Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Hepatogastroenterology ; 49(43): 41-6, 2002.
Article in English | MEDLINE | ID: mdl-11941981

ABSTRACT

BACKGROUND/AIMS: Surgical liver resection has been demonstrated in Asian countries to be the best therapeutic option in patients with hepatocellular carcinoma. Because the value of this treatment is still debated in Western countries, the aim of this paper was to report a European experience of resection for hepatocellular carcinoma. METHODOLOGY: From 1990 to 1999, 239 men and 61 women aged from 15 to 77 years old underwent 328 resections including major resection in 138 (42%) cases. Normal liver was present in 53 patients (17%) and chronic liver disease was present in 247 including 152 (50%) with cirrhosis. RESULTS: In-hospital mortality was 6.4% and was significantly influenced by the presence of chronic liver disease (1.7% vs. 7.4%). Mortality after resection in alcoholic patients (14%), in patients with hepatitis C (9%) was significantly higher than in patients chronic hepatitis B (1%) (P < 0.05). The overall survival rates were 81%, 57%, 37%, and 13% at 1, 3, 5 and 10 years. Five-year survival rate was significantly higher (P < 0.05) in patients with normal liver as compared to chronic liver disease (50% vs. 34%). In patients with chronic liver disease parameters, which significantly influenced survival rate, were vascular invasion, tumor differentiation and the extent of resection. CONCLUSIONS: In this European study with varied profile of etiologies associated with hepatocellular carcinoma we showed that a five-year survival rate of 40% can be expected after resection and that chronic liver disease is a major factor influencing short and long-term prognosis.


Subject(s)
Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/surgery , Hepatectomy/mortality , Liver Neoplasms/mortality , Liver Neoplasms/surgery , Adolescent , Adult , Aged , Carcinoma, Hepatocellular/complications , Chronic Disease , Europe , Female , Hospital Mortality , Humans , Liver Diseases/complications , Liver Neoplasms/complications , Male , Middle Aged , Survival Analysis , Survivors , Treatment Outcome
2.
Article in English | MEDLINE | ID: mdl-11294296

ABSTRACT

We report here the first case of choledochal cyst associated with a benign stenosis of the cephalic part of the main pancreatic duct. The pancreatic ductal stenosis was associated with a protein plug located upstream of the stenosis. Preoperatively, it was not possible to rule out a localized intraductal pancreatic tumor, and a pylorus-preserving pancreaticoduodenectomy was performed. This association has not been described previously, and gives new insights into the pathogenesis of acute pancreatitis associated with choledochal cyst.


Subject(s)
Choledochal Cyst/surgery , Pancreatic Ducts/pathology , Adult , Constriction, Pathologic , Female , Humans , Pancreaticoduodenectomy
3.
Hum Gene Ther ; 8(15): 1807-14, 1997 Oct 10.
Article in English | MEDLINE | ID: mdl-9358030

ABSTRACT

Antitumor gene therapy using herpes simplex type 1 thymidine kinase (TKh) and ganciclovir (GCV) treatment has revealed an important intratumoral bystander effect. A whole tumor can be eliminated when only a fraction of its tumor cells express TKh. We now report that the bystander effect not only acts within a tumor, but also between distant tumors. One TKh+ tumor was generated simultaneously with one or multiple TKh- tumors in different rat liver lobes such that there was no contact between the resulting tumors. Both the TKh+ and the TKh- tumors regressed after GCV treatment and showed infiltration with macrophages and T lymphocytes. This distant bystander effect, which is likely immune mediated, should be of major importance for gene therapy of disseminated tumors.


Subject(s)
Carcinoma, Hepatocellular/therapy , Colonic Neoplasms/therapy , Ganciclovir/therapeutic use , Genetic Therapy , Liver Neoplasms/therapy , Thymidine Kinase/genetics , 3T3 Cells , Animals , Cell Transformation, Viral , Colonic Neoplasms/secondary , Genetic Vectors , Herpesvirus 1, Human/enzymology , Liver Neoplasms/pathology , Male , Mice , Rats , Remission Induction , Thymidine Kinase/therapeutic use , Tumor Cells, Cultured
4.
J Chir (Paris) ; 132(11): 434-7, 1995 Nov.
Article in French | MEDLINE | ID: mdl-8550707

ABSTRACT

A retrospective study was conducted to evaluate the impact of laparoscopic surgery on activity in general and digestive surgery. From May 1990 to December 1994, 2256 laparoscopic procedures were performed for cholecystectomy (36%), appendicectomy (20.4%) or inguinal hernia (19.8%). 23.2% of all procedures performed in 1994 were done laparoscopically. The use of laparoscopy did not, in our experience, added any new indications from 1988 to 1994. The conversion rate was 8.15%. 24% of the conversion cases could not be predicted. Mortality was 0.18% and 1.19% of the patients had to undergo a second operation due to complications of laparsocopic surgery. The impact of laparoscopic procedures, 7 years after the first laparoscopic cholecystectomy has been great. The results of this surgical technique must be evaluated to determine its medical and economic impact.


Subject(s)
Appendectomy/methods , Cholecystectomy, Laparoscopic/methods , Hernia, Inguinal/surgery , Laparoscopy/methods , Humans , Laparotomy , Postoperative Complications , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...